PL409016A1 - N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine - Google Patents
N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamineInfo
- Publication number
- PL409016A1 PL409016A1 PL409016A PL40901614A PL409016A1 PL 409016 A1 PL409016 A1 PL 409016A1 PL 409016 A PL409016 A PL 409016A PL 40901614 A PL40901614 A PL 40901614A PL 409016 A1 PL409016 A1 PL 409016A1
- Authority
- PL
- Poland
- Prior art keywords
- polyallylamine
- sulfonic
- derivative
- medicine
- prevention
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest N-sulfonowa pochodna polialliloaminy (NSPAH) o wzorze 1, w którym R oznacza -SO3 albo -H, a n oznacza liczbę całkowitą od 150 do 15000, zastosowanie N-sulfonowej pochodnej polialliloaminy jako leku, zwłaszcza do profilaktyki i leczenia infekcji wywołanych przez wirusy grypy typu A oraz kompozycja farmaceutyczna, zawierająca N-sulfonową pochodną polialliloaminy i jej zastosowanie.The subject of the invention is an N-sulfon derivative of polyallylamine (NSPAH) of the formula 1 in which R is -SO3 or -H, and n is an integer from 150 to 15,000, the use of the N-sulfon derivative of polyallylamine as a medicine, especially for the prevention and treatment of infections caused by by influenza A viruses and a pharmaceutical composition containing the N-sulfone derivative of polyallylamine and its use.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL409016A PL228503B1 (en) | 2014-07-29 | 2014-07-29 | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine |
CA2955406A CA2955406A1 (en) | 2014-07-29 | 2015-07-29 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the... |
EP15763979.0A EP3174908B1 (en) | 2014-07-29 | 2015-07-29 | Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of the n-sulfonic polyallylamine derivative for the production of a medicine |
PCT/IB2015/055727 WO2016016820A2 (en) | 2014-07-29 | 2015-07-29 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative |
US15/329,324 US20170216347A1 (en) | 2014-07-29 | 2015-07-29 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative |
US15/792,962 US9925215B1 (en) | 2014-07-29 | 2017-10-25 | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL409016A PL228503B1 (en) | 2014-07-29 | 2014-07-29 | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine |
Publications (2)
Publication Number | Publication Date |
---|---|
PL409016A1 true PL409016A1 (en) | 2016-02-01 |
PL228503B1 PL228503B1 (en) | 2018-04-30 |
Family
ID=55178446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL409016A PL228503B1 (en) | 2014-07-29 | 2014-07-29 | N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL228503B1 (en) |
-
2014
- 2014-07-29 PL PL409016A patent/PL228503B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL228503B1 (en) | 2018-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001798A1 (en) | Pyrazine compounds for the treatment of infectious diseases. | |
PH12017500207B1 (en) | Indoles for use in influenza virus infection | |
EA201691261A1 (en) | NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS | |
EA201691726A1 (en) | NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION | |
EA201690372A1 (en) | AZAPIRIDON COMPOUNDS AND THEIR APPLICATION | |
CY1122792T1 (en) | MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS | |
EA201791916A1 (en) | 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT | |
CL2016001120A1 (en) | Compounds derived from pyrrolo1,2-f1,2,4triazine, a pharmaceutical composition that comprises them and their use in the treatment of a syncytial virus infection intermediary compounds. pct | |
EA201790571A1 (en) | PYRROPHYRIMIDINES FOR APPLICATION IN INFECTION CAUSED BY THE FLU VIRUS | |
GEP20227374B (en) | Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv) | |
EA201790758A1 (en) | Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication | |
EA201790700A1 (en) | MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES | |
EA201500383A1 (en) | DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS | |
EA201890722A1 (en) | Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication | |
EA201791614A1 (en) | INDOL DERIVATIVES AS AN INHIBITORS OF DENGE VIRUS REPLICATION | |
MX2018008803A (en) | Aryl substituted pyrimidines for use in influenza virus infection. | |
CY1118399T1 (en) | Benzofuran compounds for viral infections c treatment | |
EA201690371A1 (en) | PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION | |
MX2019002438A (en) | Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections. | |
MX2017011655A (en) | Aza-pyridone compounds and uses thereof. | |
BR112017000246A2 (en) | compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, and use of a compound or salt | |
BR112016024235A2 (en) | pharmaceutical compositions comprising antibacterial agents | |
EA201691792A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA | |
EA201690594A1 (en) | COMPOSITION FOR THE TREATMENT OF HIV INFECTION ON THE BASIS OF ATAZANAVIR AND COBICISTAT | |
EA201790632A1 (en) | 4'-VINYL-SUBSTITUTED DERIVATIVES OF NUCLEOSIDE AS A RNA REPLICATION INHIBITOR INHIBITOR WITH RESPIRATORY SYNCYTAL VIRUS |